ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO146

Phosphate Loading per Nephron Predicts CKD Progression and All-Cause Death in Patients with Nondialysis-Dependent CKD: The Fukuoka Kidney Disease Registry (FKR) Study

Session Information

  • CKD-MBD: Clinical
    October 24, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Bone and Mineral Metabolism

  • 502 Bone and Mineral Metabolism: Clinical

Authors

  • Yamada, Shunsuke, Kyushu University, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Fukuoka, Japan
  • Tanaka, Shigeru, Fukuoka Dental College, Department of Medicine, Fukuouka, Japan
  • Tsuruya, Kazuhiko, Nara Medical University, Department of Nephrology, Nara, Japan
  • Kitazono, Takanari, Kyushu University, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Fukuoka, Japan
  • Nakano, Toshiaki, Kyushu University, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Fukuoka, Japan
Background

CKD-MBD develops in the early stages of CKD and contributes to the increased risk of end-stage kidney disease and death. Thus, it is critical to identify new indicators that reflect early events of CKD-MBD and initiate appropriate interventions in the non-dialysis CKD population.

Methods

We examined 3,320 patients enrolled in the FKR study, a prospective observational study of patients with non-dialysis CKD stages G1–G5. We focused on the urinary phosphate excretion per nephron as an indicator of early CKD-MBD pathogenesis. Urinary phosphate excretion per nephron was determined by using the estimated urinary phosphate excretion divided by eGFR as a proxy for nephron number. Estimated phosphate excretion was calculated using estimated 24-hour creatinine (Cr) excretion and urinary Cr and phosphate concentrations. After patients were divided into quartiles(Q1-Q4) according to the baseline urinary phosphate loading per nephron, we determined the association of phosphate loading per nephron with the risk of all-cause death and composite kidney event using longitudinal data. The composite kidney event was defined as the development of end-stage kidney failure and/or a 1.5-fold increase in serum creatinine concentrations.

Results

Over 5 years, 1,132 patients developed a composite kidney event, and 295 died. Urinary phosphate loading per nephron elevated as early as an eGFR of 70 mL/min/1.73m2 and preceded the changes in serum PTH, calcium, and phosphorus concentrations. Multivariate-adjusted Cox proportional hazard regression analyses revealed a significant association between an increased phosphate loading per nephron and a heightened risk of developing a composite renal event and all-cause death. The hazard ratios (95%CI) for all-cause death and composite kidney events in Q4 were significantly higher than those in Q1: 1.70 (1.01-2.85) and 1.57 (1.16-2.10), respectively. These associations were independent of the serum PTH, calcium, and phosphorus concentrations.

Conclusion

Phosphate loading per nephron may reflect the early stage of CKD-MBD pathophysiology and predict CKD progression and all-cause death in patients with non-dialysis CKD. Early intervention for phosphate overload may retard the progression of CKD and decrease the death risk in this population.